Abivax S.A. ( AAVXF) - Key Metrics
AAVXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.47 | -$0.65 | -$0.65 |
| 2025Q4 | -$0.03 | -$3.38 | -$1.03 | -$1.03 |
| 2025Q2 | $0.03 | -$1.59 | -$1.05 | -$1.05 |
| 2024Q4 | $0.06 | -$1.50 | -$1.09 | -$1.10 |
| 2024Q2 | $0.11 | -$1.30 | -$1.35 | -$1.36 |
AAVXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -11.91 |
| 2025Q4 | 0% | -7.81 |
| 2025Q2 | 0% | -0.97 |
| 2024Q4 | 0% | -1.19 |
| 2024Q2 | 0% | -2.71 |
AAVXF
Price: $139
52 week price:
Earnings Per Share: -6.06 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.2 billion